Pyoderma gangrenosum following COVID-19 infection
- PMID: 34567448
- PMCID: PMC8462916
- DOI: 10.1080/20009666.2021.1958492
Pyoderma gangrenosum following COVID-19 infection
Keywords: COVID-19; Pyoderma gangrenosum; inflammatory skin disorders; neutrophilic dermatosis; non-healing ulcers; skin ulcers.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- Patel F, Fitzmaurice S, Duong C, et al. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015May;95(5):525–531. - PubMed
-
- Lee WS, Choi YJ, Yoo WH. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis. J Eur Acad Dermatol Venereol. 2017Feb;31(2):e75–e77. Epub 2016 Jun 21. - PubMed
Publication types
LinkOut - more resources
Full Text Sources